Improved relative survival in older patients with acute myeloid leukemia over a 30-year period in the Netherlands: a long haul is needed to change nothing into something

Leukemia. 2022 Feb;36(2):596-598. doi: 10.1038/s41375-021-01503-y. Epub 2022 Jan 17.

Z L Rana Kaplan^{1

2}, Nikki van Leeuwen¹, Eduardus F M Posthuma^{3

4}, Otto Visser⁵, Gerwin Huls⁶, Arjan A van de Loosdrecht⁷, Avinash G Dinmohamed^{8

9

10}

¹ Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
² Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
³ Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.
⁴ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
⁵ Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
⁶ Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
⁷ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
⁸ Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.
⁹ Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.
¹⁰ Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.

No abstract available

Publication types